|
1
|
Tschopp R and Kidanu AG:
Knowledge-attitude and practice of Anthrax and brucellosis:
Implications for zoonotic disease surveillance and control in
pastoral communities of Afar and Somali region, Ethiopia. PLoS Negl
Trop Dis. 18(e0012067)2024.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Nana SD, Caffin JH, Duboz R,
Antoine-Moussiaux N, Binot A, Diagbouga PS, Hendrikx P and Bordier
M: Towards an integrated surveillance of zoonotic diseases in
Burkina Faso: The case of anthrax. BMC Public Health.
22(1535)2022.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Bradley JS, Bulitta JB, Cook R, Yu PA,
Iwamoto C, Hesse EM, Chaney D, Yu Y, Kennedy JL, Sue D, et al:
Central nervous system antimicrobial exposure and proposed dosing
for anthrax meningitis. Clin Infect Dis. 78:1451–1457.
2024.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Blackburn JK, Kenu E, Asiedu-Bekoe F,
Sarkodie B, Kracalik IT, Bower WA, Stoddard RA and Traxler RM: High
case-fatality rate for human anthrax, Northern Ghana, 2005-2016.
Emerg Infect Dis. 27:1216–1219. 2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Zhang EM, Zhang HJ, He JR, Li W and Wei
JC: Analysis of epidemic characteristics of anthrax in China from
2017 to 2019 and molecular typing of Bacillus anthracis. Zhonghua
Yu Fang Yi Xue Za Zhi. 56:422–426. 2022.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
6
|
Caffes N, Hendricks K, Bradley JS,
Twenhafel NA and Simard JM: Anthrax meningoencephalitis and
intracranial hemorrhage. Clin Infect Dis. 75 (Suppl 3):S451–S458.
2022.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Zhou G, Wang H, Zhang X, Yu L, Yao F, Li B
and Fang Q: Cerebral arteriosclerosis stenosis predicts poor
short-term prognosis in non-valvular atrial fibrillation related
cardioembolic stroke treated by reperfusion therapy. Clin Neurol
Neurosurg. 207(106738)2021.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Gozdas HT, Dogan A, Wright H and Fox-Lewis
A: Laboratory findings in acute bacterial meningitis and acute
viral encephalitis. N Z Med J. 137:103–104. 2024.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Bhattacharya D, Kshatri JS, Choudhary HR,
Parai D, Shandilya J, Mansingh A, Pattnaik M, Mishra K, Padhi SP,
Padhi A and Pati S: One Health approach for elimination of human
anthrax in a tribal district of Odisha: Study protocol. PLoS One.
16(e0251041)2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zhang H, Zhang E, Guo M, He J, Li W and
Wei J: Epidemiological characteristics of human Anthrax - China,
2018-2021. China CDC Wkly. 4:783–787. 2022.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kutmanova A, Zholdoshev S, Roguski KM,
Sholpanbay Uulu M, Person MK, Cook R, Bugrysheva J, Nadol P,
Buranchieva A, Imanbaeva L, et al: Risk factors for severe
cutaneous anthrax in a retrospective case series and use of a
clinical algorithm to identify likely meningitis and evaluate
treatment outcomes, kyrgyz republic, 2005-2012. Clin Infect Dis. 75
(Suppl 3):S478–S486. 2022.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Thompson JM, Cook R, Person MK, Negrón ME,
Traxler RM, Bower WA and Hendricks K: Risk factors for death or
meningitis in adults hospitalized for cutaneous anthrax, 1950-2018:
A systematic review. Clin Infect Dis. 75 (Suppl 3):S459–S467.
2022.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Sidwa T, Salzer JS, Traxler R, Swaney E,
Sims ML, Bradshaw P, O'Sullivan BJ, Parker K, Waldrup KA, Bower WA
and Hendricks K: Control and Prevention of Anthrax, Texas, USA,
2019. Emerg Infect Dis. 26:2815–2824. 2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Ben-Shmuel A, Glinert I, Sittner A,
Bar-David E, Schlomovitz J, Levy H and Weiss S: Doxycycline,
levofloxacin, and moxifloxacin are superior to ciprofloxacin in
treating anthrax meningitis in rabbits and NHP. Antimicrob Agents
Chemother: Apr 30, 2024 (Epub ahead of print).
|
|
15
|
Wicky PH, Poiraud J, Alves M, Patrier J,
d'Humières C, Lê M, Kramer L, de Montmollin É, Massias L,
Armand-Lefèvre L and Timsit JF: Cefiderocol treatment for severe
infections due to difficult-to-treat-resistant non-fermentative
Gram-Negative Bacilli in ICU patients: A case series and narrative
literature review. Antibiotics (Basel). 12(991)2023.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Zhou ZM, Gu LL, Zhou ZY and Liang QL:
Recent Advance of S100B proteins in spontaneous intracerebral
hemorrhage and aneurysmal subarachnoid hemorrhage. Front Biosci
(Landmark Ed). 29(37)2024.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Bobinger T, Roeder SS, Spruegel MI,
Froehlich K, Beuscher VD, Hoelter P, Lücking H, Corbeil D and
Huttner HB: Variation of membrane particle-bound CD133 in
cerebrospinal fluid of patients with subarachnoid and intracerebral
hemorrhage. J Neurosurg. 134:600–607. 2021.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Zhao X, Zhou B, Luo Y, Chen L, Zhu L,
Chang S, Fang X and Yao Z: CT-based deep learning model for
predicting hospital discharge outcome in spontaneous intracerebral
hemorrhage. Eur Radiol. 34:4417–4426. 2024.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Conklin J and Lev MH: Beyond the AJR:
Intracranial CTA versus lumbar puncture for suspected subarachnoid
hemorrhage with negative head CT. AJR Am J Roentgenol: Jul 17, 2024
(Epub ahead of print).
|
|
20
|
Li JH, Wu D, Yin ZD and Li YX: Analysis of
epidemic characteristics for meningococcal meningitis in China
during 2015-2017. Zhonghua Yu Fang Yi Xue Za Zhi. 53:159–163.
2019.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
21
|
Bita Fouda AA, Latt A, Sinayoko A,
Mboussou FFR, Pezzoli L, Fernandez K, Lingani C, Miwanda B, Bulemfu
D, Baelongandi F, et al: The bacterial meningitis epidemic in
banalia in the democratic republic of congo in 2021. Vaccines
(Basel). 12(461)2024.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Zhai LN, Zhao Y, Song XL, Qin TT, Zhang
ZJ, Wang JZ, Sui CY, Zhang LL, Lv M, Hu LF, et al: Inhalable
vaccine of bacterial culture supernatant extract mediates
protection against fatal pulmonary anthrax. Emerg Microbes Infect.
12(2191741)2023.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Vrinceanu D, Dumitru M, Patrascu OM,
Costache A, Papacocea T and Cergan R: Current diagnosis and
treatment of rhinosinusal aspergilloma (Review). Exp Ther Med.
22(1264)2021.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Beliveau M, Rubets I, Bojan D, Hall C,
Toth D, Kodihalli S and Kammanadiminti S: Animal-to-Human dose
translation of ANTHRASIL for treatment of inhalational anthrax in
healthy adults, obese adults, and pediatric subjects. Clin
Pharmacol Ther. 115:248–255. 2024.PubMed/NCBI View
Article : Google Scholar
|
|
25
|
Doganay M, Dinc G, Kutmanova A and Baillie
L: Human Anthrax: Update of the diagnosis and treatment.
Diagnostics. 13(1056)2023.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Person MK, Cook R, Bradley JS, Hupert N,
Bower WA and Hendricks K: Systematic review of hospital treatment
outcomes for naturally acquired and bioterrorism-related anthrax,
1880-2018. Clin Infect Dis. 75 (Suppl 3):S392–S401. 2022.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Bower WA, Yu Y, Person MK, Parker CM,
Kennedy JL, Sue D, Hesse EM, Cook R, Bradley J, Bulitta JB, et al:
CDC guidelines for the prevention and treatment of anthrax, 2023.
MMWR Recomm Rep. 72:1–47. 2023.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Matharoo K, Chua J, Park JR, Ingavale S,
Jelacic TM, Jurkouich KM, Compton JR, Meinig JM, Chabot D,
Friedlander AM and Legler PM: Engineering an Fc-Fusion of a capsule
degrading enzyme for the treatment of anthrax. ACS Infect Dis.
8:2133–2148. 2022.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Lin C, Dou X, Zhang D, Sun Y, Han H, Chen
C, Zhang X, Li S, Chen Y, Zhang H, et al: Epidemiological
Investigation of an Inhalational Anthrax Patient Traveling for
Medical Treatment in Beijing Municipality, China, August 2021.
China Cdc Wkly. 4:4–7. 2022.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Hesse EM, Godfred-Cato S and Bower WA:
Antitoxin use in the prevention and treatment of anthrax disease: A
systematic review. Clin Infect Dis. 75 (Suppl 3):S432–S440.
2022.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Aktories K: Treatment of ovarian cancer
with modified anthrax toxin. Proc Natl Acad Sci USA.
119(e2210179119)2022.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Martchenko Shilman M, Bartolo G, Alameh S,
Peterson JW, Lawrence WS, Peel JE, Sivasubramani SK, Beasley DWC,
Cote CK, Demons ST, et al: In vivo activity of repurposed
amodiaquine as a host-targeting therapy for the treatment of
anthrax. ACS Infect Dis. 7:2176–2191. 2021.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Legler PM, Little SF, Senft J, Schokman R,
Carra JH, Compton JR, Chabot D, Tobery S, Fetterer DP, Siegel JB,
et al: Treatment of experimental anthrax with pegylated circularly
permuted capsule depolymerase. Sci Transl Med.
13(eabh1682)2021.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Jauro S, Ndumnego OC, Ellis C, Buys A,
Beyer W and Heerden HV: Immunogenicity and protective efficacy of a
non-living anthrax vaccine versus a live spore vaccine with
simultaneous penicillin-G treatment in cattle. Vaccines (Basel).
8(595)2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Oh J, Jo H, Park J, Lee H, Kim HJ, Lee H,
Kang J, Hwang J, Woo S, Son Y, et al: Global burden of
vaccine-associated rheumatic diseases and their related vaccines,
1967-2023: A comprehensive analysis of the international
pharmacovigilance database. Int J Rheum Dis.
27(e15294)2024.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Schneider SN, Nguyen TQ, Hake KL,
Nightingale BS, Mangan TP, Rice AN and Carroll JC: Development of a
pharmacy point-of-dispensing toolkit for anthrax post-exposure
prophylaxis for allegheny county postal workers. J Public Health
Manag Pract. 30:231–239. 2024.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Li S, Ma Q, Chen H, Liu Y, Yao G, Tang G
and Wang D: Epidemiological investigation and etiological analysis
of a cutaneous anthrax epidemic caused by Butchering Sick Cattle in
Guizhou, China. Front Public Health. 8(65)2020.PubMed/NCBI View Article : Google Scholar
|
